The weekly litigation news digest is live. Subscribe now

IP Verse

Stable Liquid Formulation Of Amg 416 Hcl (Etelcalcetide) - EP3246017

The patent EP3246017 was granted to Amgen on Mar 24, 2021. The application was filed on Jun 27, 2014 under application number EP17160312A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3246017

AMGEN
Application Number
EP17160312A
Filing Date
Jun 27, 2014
Status
Granted And Under Opposition
Feb 19, 2021
Publication Date
Mar 24, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ADALVODec 22, 2021SLAVIKADMISSIBLE
STADA ARZNEIMITTELDec 22, 2021HAMM & WITTKOPPADMISSIBLE
SYNTHONDec 22, 2021HAMM & WITTKOPPADMISSIBLE
FRESENIUS KABI DEUTSCHLANDDec 21, 2021FRESENIUS KABI DEUTSCHLANDADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2011014707
OPPOSITIONEP2399604
OPPOSITIONWO2007040711
OPPOSITIONWO2012170955
OPPOSITIONWO2013071262
SEARCHWO2011014707
SEARCHWO2015154031

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents